One part of our firm's mission is to assist our clients with bringing as many therapeutic drugs and medical devices to market as possible. Our firm's pharmaceutical lifecycle management lawyers have assisted our clients with developing strong pharmaceutical lifecycle management strategies at every stage of the patent term.
The purpose of managing a drug's patent lifecyle is to legally protect a company's ability to improve the safety and efficacy ("effectiveness," in other words) of the underlying drug to treat a certain medical condition. In addition, this legal protection provides an incentive for the company to research and invent new forms of the drug, and possibly new methods of treating unexpected medical conditions, which were not conceived at the time of the original invention. In our view, that is a win-win result that is good for everyone involved.
Our clients spend billions of dollars researching, developing, and creating a recognized market for a *single* drug to help patients in need. High failure rates, the long term investment needed for research and development, and the very tall hurdles erected by each international jurisdiction into which our clients seek to enter make the business of drug development very risky.
In fact, more than a decade will have passed after a first patent application is filed when a putative new therapeutic substance might be approved for sale. Because only 1 or 2 in every 10,000 substances synthesised will meet the high hurdles of safety and effecacy, we help our clients maximize their investment in researching and developing lifesaving therapies.
Generally, a PLM strategy will involve a variety of related patent application submissions:
These strategies involve not only submitting Continuation, Continuation-in-Part, Divisional applications, Patent Term Extension, and Patent Term Adjustment under US federal law, but also patenting inventions related to novel and non-obvious:
The patent attorneys, engineers, scientists, and patent agents at Torrey Pines Law Group have worked in a variety of pharmaceutical industries, both branded and generic, and have assisted with commercializing, researching, and developing pharmaceutical technologies including:
We welcome the opportunity to provide you more detailed information about our firm and see how we can work together. Please contact us to schedule a free initial consultation, and follow us on Facebook, Twitter, and LinkedIn.
COPYRIGHT ©
, TORREY PINES LAW GROUP, PC. ALL RIGHTS RESERVED. | LEGAL NOTICES | SITE MAP | PAYMENTS | STANDARD FIRM CHARGES
Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.
We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.
Pharmaceutical Patent Attorneys - Pharmaceutical Patent Preparation & Prosecution Lawyer - Pharmaceutical Intellectual Property Litigation Law Firm - San Francisco Biopharmaceutical IP - New Jersey Pharmaceutical Lawyers - Cambridge Pharmaceutical Counsel